Vio3
Payments companies reported to CMS as associated with Vio3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3
These are the largest totals companies reported as associated with Vio3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Draganov | Gainesville, FL | Gastroenterology (Internal Medicine) | $639.75 |
| Amy Hosmer | Pittsburgh, PA | Gastroenterology (Internal Medicine) | $550.00 |
| Talal Seoud | Chillicothe, OH | Gastroenterology (Internal Medicine) | $539.75 |
| Tiffany Chua | Gainesville, FL | Gastroenterology (Internal Medicine) | $539.75 |
| Petros Benias | New, NY | Gastroenterology (Internal Medicine) | $365.00 |
| Calvin Lee | Manhasset, NY | Gastroenterology (Internal Medicine) | $365.00 |
| Mary Cheung | Bronx, NY | Internal Medicine | $365.00 |
| Bethany Devito | Manhasset, NY | Gastroenterology (Internal Medicine) | $365.00 |
| Kara Raphael | New Hyde Park, NY | Internal Medicine | $365.00 |
| Juan Carlos Bucobo | Stony Brook, NY | Gastroenterology (Internal Medicine) | $365.00 |
Prescribed Vio3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.